In-vitro activity of tigecycline and comparator agents against common pathogens: Indian experience | Zendy

Balaji Veeraraghavan | Zendy; Aruna Poojary | Zendy; Chaitra Shankar | Zendy; Anurag Kumar Bari | Zendy; Seema Kukreja | Zendy; Bhuvaneswari Thukkaram | Zendy; Ramya Gajaraj Neethimohan | Zendy; Yamuna Devi Bakhtavachalam | Zendy; Shweta Kamat | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

In-vitro activity of tigecycline and comparator agents against common pathogens: Indian experience

Author(s) -

Balaji Veeraraghavan,

Aruna Poojary,

Chaitra Shankar,

Anurag Kumar Bari,

Seema Kukreja,

Bhuvaneswari Thukkaram,

Ramya Gajaraj Neethimohan,

Yamuna Devi Bakhtavachalam,

Shweta Kamat

Publication year - 2019

Publication title -

the journal of infection in developing countries

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.322

H-Index - 49

eISSN - 2036-6590

pISSN - 1972-2680

DOI - 10.3855/jidc.10376

Subject(s) - tigecycline , microbiology and biotechnology , enterobacter cloacae , broth microdilution , enterobacter , klebsiella oxytoca , enterococcus faecalis , biology , antibiotics , klebsiella , klebsiella pneumoniae , medicine , minimum inhibitory concentration , staphylococcus aureus , bacteria , escherichia coli , biochemistry , genetics , gene

Tigecycline Evaluation and Surveillance Trail (TEST) study is an on-going global surveillance. The study was performed to determine the susceptibility of common pathogens to tigecycline and comparator antibiotics by broth microdilution (BMD) at two tertiary care centres in India from 2015 to 2017.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research